PT654267E - Carcinoestaticos para terapia hormonal contendo dienogest como componente eficaz - Google Patents

Carcinoestaticos para terapia hormonal contendo dienogest como componente eficaz

Info

Publication number
PT654267E
PT654267E PT94118050T PT94118050T PT654267E PT 654267 E PT654267 E PT 654267E PT 94118050 T PT94118050 T PT 94118050T PT 94118050 T PT94118050 T PT 94118050T PT 654267 E PT654267 E PT 654267E
Authority
PT
Portugal
Prior art keywords
carcinostatics
effective component
hormonal therapy
therapy containing
containing dienogest
Prior art date
Application number
PT94118050T
Other languages
English (en)
Inventor
Yasunori Shibutani
Masaomi Obata
Masami Sato
Yukio Katsuki
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of PT654267E publication Critical patent/PT654267E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT94118050T 1993-11-19 1994-11-15 Carcinoestaticos para terapia hormonal contendo dienogest como componente eficaz PT654267E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29082393 1993-11-19

Publications (1)

Publication Number Publication Date
PT654267E true PT654267E (pt) 2002-09-30

Family

ID=17760949

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94118050T PT654267E (pt) 1993-11-19 1994-11-15 Carcinoestaticos para terapia hormonal contendo dienogest como componente eficaz

Country Status (9)

Country Link
US (1) US5652231A (pt)
EP (1) EP0654267B1 (pt)
AT (1) ATE215826T1 (pt)
AU (1) AU683098B2 (pt)
CA (1) CA2136140C (pt)
DE (1) DE69430356T2 (pt)
DK (1) DK0654267T3 (pt)
ES (1) ES2176218T3 (pt)
PT (1) PT654267E (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4418102B2 (ja) * 1997-10-17 2010-02-17 持田製薬株式会社 ジエノゲストを有効成分とする子宮筋腫治療剤
AU1690399A (en) * 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Neovascularization inhibitor containing dienogest as the active ingredient
EP1043331A4 (en) * 1997-12-26 2002-05-15 Mochida Pharm Co Ltd DIENOGEST CONTAINING OSTEORESORPTION CYTOKINE INHIBITOR AS ACTIVE INGREDIENT
DE19825591A1 (de) * 1998-06-09 1999-12-23 Jenapharm Gmbh Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
DE19908762A1 (de) * 1999-02-18 2000-08-31 Jenapharm Gmbh Verwendung von Dienogest in hoher Dosierung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718872A1 (de) * 1976-06-14 1977-12-22 Jenapharm Veb Verfahren zur herstellung von neuen gona-4,9(10)-dienen
JPS6372627A (ja) * 1986-09-17 1988-04-02 Mitsubishi Kasei Corp 子宮内膜症治療薬
JPS643121A (en) * 1987-06-25 1989-01-06 Mitsubishi Kasei Corp Remedy for endometriosis
KR0181264B1 (ko) * 1989-07-07 1999-03-20 라브리 페르낭 성스테로이드 활성 억제용 안드로겐 유도체

Also Published As

Publication number Publication date
US5652231A (en) 1997-07-29
DK0654267T3 (da) 2002-05-13
EP0654267A1 (en) 1995-05-24
CA2136140A1 (en) 1995-05-20
DE69430356T2 (de) 2002-08-14
CA2136140C (en) 2007-10-30
ATE215826T1 (de) 2002-04-15
DE69430356D1 (de) 2002-05-16
AU683098B2 (en) 1997-10-30
ES2176218T3 (es) 2002-12-01
AU7888394A (en) 1995-05-25
EP0654267B1 (en) 2002-04-10

Similar Documents

Publication Publication Date Title
BR0113447A (pt) Método de tratamento ou prevenção do câncer em um ser humano, e, composição farmacêutica
ES2153862T3 (es) Bisulfan de administracion parenteral para el tratamiento de enfermedades malignas.
EP1033981A4 (en) FORMULATIONS AND METHODS FOR REDUCING THE TOXICITY OF ANTINEOPLASTIC AGENTS
ES2123642T3 (es) Metodo para el tratamiento del cancer por terapia conjunta con derivados de 2'-halometilideno y un agente antineoplasico especifico de fase s o fase m.
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
PT871468E (pt) Metodos para tratar cancro da prostata com antagonistas de lhrh
MX9707569A (es) Un metodo para el tratamiento de la degeneracion macular.
MXPA05002883A (es) Formas de dosis y terapias relacionadas.
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
SE7612534L (sv) Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
CA2108963A1 (en) Compositions and Methods for Therapy and Prevention of Cancer, Aids and Anemia
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
PT654267E (pt) Carcinoestaticos para terapia hormonal contendo dienogest como componente eficaz
HK1043315A1 (en) Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma.
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
KR927002224A (ko) 항종양효과증강제 및 항종양제
BR0015121A (pt) Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação
BR0114856A (pt) Combinação compreendendo camptotecina e um derivado de estilbeno para o tratamento de câncer
EP0617962A4 (en) AGENT AGAINST OBESITY.
ZA943342B (en) The use of compositions for combating tumour diseases
BRPI0416316A (pt) combinação de um inibidor da farnesil transferase com um agente anti-hormonal para o tratamento de cáncer de mama
HK1061530A1 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy.
KR930019216A (ko) 종양 치료제
AUPM496094A0 (en) Improved orthotic device for the treatment of patella tendon disorders incorporating therapeutic pulsed electromagnetic field therapy